Yashika kapoor ,
The Med Guru |
In a development that may herald a new breakthrough in stem cell research, the FDA has approved human trials of stem cell in treating blindness.
Reportedly, the U.S Food and Drug administration has given thumbs up to Advanced Cell Technology (ACT), an American stem cell research company, to test an embryonic stem cell treatment on patients having a rare disease that triggers blindness.
It may be noted that ACT is the second company in the United States to test a human embryonic stem cell therapy and will treat 12 patients diagnosed with Stargardt’s macular dystrophy.